HIV associated nephropathy screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 3: Line 3:
{{CMG}}{{APM}};{{AE}} {{SHA}} {{KW}}
{{CMG}}{{APM}};{{AE}} {{SHA}} {{KW}}
==Overview==
==Overview==
[[Screening (medicine)|Screening]] for kidney disease is recommended in high risk populations in all patients with seropositive [[Human Immunodeficiency Virus (HIV)|HIV-1]] (upon detection).  
[[Screening (medicine)|Screening]] for kidney disease is recommended in high risk populations in all patients with seropositive [[Human Immunodeficiency Virus (HIV)|HIV-1]] (upon detection).<ref name="pmid29872351" />  


==Screening==
==Screening==

Latest revision as of 19:22, 30 June 2020

HIV associated nephropathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating HIV associated nephropathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

KUB X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

HIV associated nephropathy screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of HIV associated nephropathy screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on HIV associated nephropathy screening

CDC on HIV associated nephropathy screening

HIV associated nephropathy screening in the news

Blogs on HIV associated nephropathy screening

Directions to Hospitals Treating HIV associated nephropathy

Risk calculators and risk factors for HIV associated nephropathy screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2];Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[3] Krzysztof Wierzbicki M.D. [4]

Overview

Screening for kidney disease is recommended in high risk populations in all patients with seropositive HIV-1 (upon detection).[1]  

Screening

Screening for kidney disease is recommended in high risk populations in all patients with seropositive HIV-1 (upon detection).[1]

HIV screening

  • According to the U.S. Preventive Service Task Force, clinicians should screen for HIV in:
    • Adolescents and adults ages 15 to 65
    • Pregnant Persons
  • Center of Disease Control (CDC) recommendations for HIV screening:
    • People between the ages of 13 and 64 should get tested for HIV at least once.
    • Those with risk factors for HIV are recommended to be screened more frequently. The CDC suggests that people with risk factors should be tested at least once a year.
    • Asymptomatic sexually active men who have sex with men (MSM) should be screened once a year. The benefits of more frequent screening ( once every 3 or 6 months) for MSM at increased risk for HIV infection should be considered.

References

  1. 1.0 1.1 Palau L, Menez S, Rodriguez-Sanchez J, Novick T, Delsante M, McMahon BA; et al. (2018). "HIV-associated nephropathy: links, risks and management". HIV AIDS (Auckl). 10: 73–81. doi:10.2147/HIV.S141978. PMC 5975615. PMID 29872351.

Template:WH Template:WS